Summary
The breast cancer drug Herceptin has been approved for use on the NHS, under draft guidance issued by the Government's health watchdog yesterday.
The National Institute for Health and Clinical Excellence (Nice) recommended the drug for those with early stage HER2-positive breast cancer, except where there are concerns about the woman's heart function.See the full content of this document
Extract
Nhs Cleared to Use Herceptin
The guidance is still open to consultation and a final version will be issued early next month.
The move co...See the full content of this document
Sponsored links
